« go back

Brexit Is Chance to Spur Biotechnology, May’s Policy Chief Says

By Amy Tayler

A Bloomberg markets article reports that Brexit is an incredible opportunity for the U.K. to push its expertise in biotechnology and other sciences as the country is freed from burdensome European Union regulation, according to George Freeman, the chairman of Prime Minister Theresa May’s policy board. Read the full article here.

Subscribe to our updates

Subscribe to our newsletters
Follow us on twitter

Join us on LinkedIn

Keep up to date with the latest agri-food and biosciences news, events, funding opportunities and more.

Read our latest newsletter

Subscribe to our RSS feed

Subscribe to our SynBio SIG RSS news feed by adding this link to your favourite news reader.

Send us your news

Got a great news story, event or funding opportunity relevant to the synthetic biology community?

Email us: